Keywords: AFib; atrial fibrillation; TSG; tumor suppressor gene; CM; cardiomyocytes; GWAS; genome-wide association studies; SR; sinus rhythm; SNP; small nucleotide polymorphism; ECRG4; esophageal cancer related gene-4; ZFHX3; zinc finger homeobox protein-3; Cx; con
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AAb; autoantibody; AUC; area under the curve; BSA; bovine serum albumin; CA-125; cancer antigen 125; CI; confidence interval; DD; doublet discriminator; IgG; immunoglobulin G; OVCA; ovarian cancer; PBS; phosphate buffered saline; PPV; positive predictive
Keywords: Ovarian cancer; Diagnostics; Biospectroscopy; Raman; SERS; CA-125;
Keywords: Blood coagulation; Tissue factor; Thrombin; Platelets; Protease-activated receptors; Metastasis; AT; antithrombin; BMI; body mass index; CA-125; cancer antigen 125; CCC; clear cell carcinoma; CD; cluster of differentiation; CG; control group; DVT; deep ve
Keywords: Ovarian cancer; Lymph node metastases; Lymphadenectomy; CA-125; Histology type
Keywords: BCL-2; B-cell lymphoma 2; CA-125; cancer antigen-125; CAFs; cancer-associated fibroblasts; CCL17; chemokine (C-C motif) ligand 17; CCL2; chemokine (C-C motif) ligand 2; CXCL12; chemokine (C-X-C motif) ligand 12; DFS; disease-free survival; DNMT; DNA methy
Keywords: Biomarker; CA-125; C-reactive protein; endometriosis; neurotrophin;
Keywords: Non-Hodgkin's lymphoma; Pelvic mass, gynecological origin; CA-125;
Keywords: CA-125; CA 19-9; diagnostic marker; endometriosis; follistatin
Keywords: Ca-125; Deep infiltrating endometriosis; Endometrioma; Endometriosis;
Keywords: adnexal mass; CA-125; ovarian cancer; risk of malignancy index; Wales
Keywords: Ovarian cancer; Screening; Transvaginal ultrasound; CA-125; Harm; Systematic review;
Keywords: Ca-125; Fallopian tube carcinoma; Metastases; Ovarian cancer; Paraaortic lymph nodes
Nonbacterial Thrombotic Endocarditis Complicated by Cerebral Infarction in a Patient with Adenomyosis with High Serum CA125 Level; A Case Report
Keywords: Cerebral infarction; nonbacterial thrombotic endocarditis; adenomyosis; CA-125; mucin;
Aggressive neuroendocrine tumor of the ovary with multiple metastases treated with everolimus: A case report
Keywords: Carcinoid; Everolimus; Multiple metastases; Neuroendocrine tumor; Ovary; NETs; neuroendocrine tumors; FIGO; International Federation of Gynecology and Obstetrics; mTOR; mammalian target of rapamycin; MRI; magnetic resonance imaging; CT; computed tomograph
Standard and optimal cut-off values of serum ca-125, HE4 and ROMA in preoperative prediction of ovarian cancer in Vietnam
Keywords: Epithelial ovarian cancer; CA-125; HE4; ROMA;
Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer
Keywords: Ovarian cancer; MicroRNA; Cytoreduction; CA-125; Surgical outcome;
Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125
Keywords: Sandwich ELISA; CA-125; HE4; TTR; Diagnosis; Ovarian cancer;
Current advancement on diagnosis of ovarian cancer using biosensing of CA 125 biomarker: Analytical approaches
Keywords: Biomedical analysis; CA-125; Biosensor; Ovarian cancer; Biomarker; MUCIN 16; Nanomaterials;
Epithelioid angiosarcoma arising in a uterine leiomyoma with associated elevated CA-125: A case report
Keywords: Angiosarcoma; Epithelioid; Leiomyoma; CA-125;
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer
Keywords: Ovarian cancer; CT scan; CA-125; Primary debulking; Gross residual disease;
Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival
Keywords: Ovarian cancer; Cancer screening; CA-125; Overdiagnosis;
Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer
Keywords: AIC; Akaike Information Criteria; AUC; area under the curve; BMI; body mass index; ECLIA; electrochemiluminescent immunoassay; ROC; receiver operating characteristics; Endometrial cancer; Biomarkers; CA-125; HE4; Algorithm; Prognosis; Logistic regression;
A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)-only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer
Keywords: Epacadostat; Ovarian cancer; Tamoxifen; Ca-125; IDO1 enzyme inhibitor;
Electrochemical immunosensor based on ZnO nanorods-Au nanoparticles nanohybrids for ovarian cancer antigen CA-125 detection
Keywords: Electrochemical immunosensor; ZnO; Nanohybrid materials; CA-125; Au nanoparticles;
ACR Appropriateness Criteria® Ovarian Cancer Screening
Keywords: Appropriateness Criteria; Appropriate Use Criteria; AUC; CA-125; Cancer screening; Ovarian cancer; Pelvic US;
Ultrasound molecular imaging of ovarian cancer with CA-125 targeted nanobubble contrast agents
Keywords: Targeted contrast agents; Nanobubbles; Ca-125; Contrast enhanced ultrasound; Molecular imaging; Ovarian cancer;
High CA-125 and CA19-9 levels in spontaneous ruptured ovarian endometriomas
Keywords: Spontaneous rupture; CA-125; CA19-9; Ovarian endometrioma
Novel markers in the diagnostics of endometriomas: Urocortin, ghrelin, and leptin or leukocytes, fibrinogen, and CA-125?
Keywords: CA-125; ghrelin; leptin; leukocytes; endometriomas
Abnormal CA-125 levels in menopausal women without ovarian cancer
Keywords: CA-125; PLCO; Ovarian cancer screening;
Maternal serum CA-125 level is elevated in severe preeclampsia
Keywords: CA-125; Pre-eclampsia; Pregnancy
The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study
Keywords: Ovarian cancer; Low grade serous carcinoma; CA-125;
Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125
Keywords: Ovarian cancer; Peritoneal metastases; 18F-FDG PET/CT; Contrast enhanced CT; Ca-125; Cáncer de ovario; Metástasis peritoneales; 18F-FDG PET/CT; CT contraste; Ca-125;
Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125
Keywords: Ovarian cancer; Peritoneal metastases; 18F-FDG PET/CT; Contrast enhanced CT; Ca-125Cáncer de ovario; Metástasis peritoneales; 18F-FDG PET/CT; CT contraste; Ca-125
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer
Keywords: Ovarian cancer; CA-125; CT scan; Suboptimal cytoreduction;
Dynamic modeling in ovarian cancer: An original approach linking early changes in modeled longitudinal CA-125 kinetics and survival to help decisions in early drug development
Keywords: CA-125; Ovarian cancer; Progression-free survival; Drug development
Preoperative CA 15-3 levels predict the prognosis of nonmetastatic luminal A breast cancer
Keywords: Serum tumor markers; CA 15-3; Breast cancer; Metastasis; CA-125; CEA
Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age
Keywords: HE4; CA-125; CEA; Adnexal mass; Ovarian cancer;
Short-Term Morbidity and Clinical Response After a 2-Week Versus 6-Week Interval From Debulking Surgery to Adjuvant Chemotherapy in Epithelial Ovarian Cancer
Keywords: CA-125; Chemotherapy; Debulking surgery; Morbidity; Ovarian cancer
Comparison of Ki-67 proliferative index between eutopic and ectopic endometrium: A case control study
Keywords: endometriosis; Ki-67 proliferative index; Ca-125
Preoperative serum CA 125 level in the prediction of the stage of disease in endometrial carcinoma
Keywords: Endometrial carcinoma; CA-125; Lymph node metastasis; Lymphadenectomy; Cutoff value
Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer
Keywords: CA-125; Ovarian cancer; Screening; Velocity;
Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial ★
Keywords: Ovarian cancer; Bevacizumab; CA-125; Phase II trial; Response assessment
Role of some biomarkers in chronic pelvic pain for early detection of endometriosis in infertile women
Keywords: Chronic pelvic pain; Endometriosis; Biomarkersl; IL-6; TNF-α; Us-CRP; CA-125; VEGF
Ovarian fibroma with marked ascites and elevated serum levels of CA-125 in a young girl
Keywords: Fibroma; Ascites; CA-125; Children;
Ovarian cancer patient surveillance after curative-intent initial treatment
Keywords: Ovarian cancer; Surveillance; Follow-up; FIGO staging; CA-125;
Disseminated peritoneal tuberculosis simulating advanced ovarian cancer: A retrospective study of 17 cases
Keywords: Ascites; CA-125; Extrapulmonary tuberculosis; Ovarian cancer; Peritoneal tuberculosis
Interaction between preoperative CA-125 level and survival benefit of neoadjuvant chemotherapy in advanced epithelial ovarian cancer
Keywords: Ovarian cancer; Neoadjuvant chemotherapy; Optimal cytoreduction; CA-125; Risk factor
Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial
Keywords: Ovary; Screening; Transvaginal ultrasound; CA-125; False-positive; Histopathology
Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study
Keywords: CA-125; Rustin criteria; Platinum; Relapsed ovarian cancer; Trabectedin